Diversity in the acute CD8 T cell response to vaccinia virus in humans

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7550-7559

  Jing, Lichen ^a   Chong, Tiana M ^a   McClurkan, Christopher L ^a   Huang, Jay ^a   Story, Brian T ^a   Koelle, David M ^a,b,c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; POLYPEPTIDE; PROTEOME; TRANSCRIPTION FACTOR; VIRUS DNA;

ADULT; ALLELE; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; CLONE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA LIBRARY; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONKEYPOX VIRUS; NONHUMAN; OPEN READING FRAME; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROTEIN TARGETING; SMALLPOX VIRUS; T LYMPHOCYTE; TECHNIQUE; VACCINATION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 28244446709     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7550     Document Type: Article

References (54)

1. Musey, L., Y. Ding, M. Elizaga. R. Ha, C. Celum, and M. J. McElrath. 2003. HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals. J. Immunol. 171: 1094-1101.
2. Redfield, R. R., D.C. Wright, W. D. James, T. S. Jones, C. Brown, and D.S. Burke. 1987. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N. Engl. J. Med. 316: 673-676.
3. Fulginiti, V. A., A. Papier, J. M. Lane, J. M. Neff, and D. A. Henderson. 2003. Smallpox vaccination: a review, part II. Adverse events. Clin. Infect. Dis. 37: 251-271.
4. Engler, R. J., J. Kenner, and D. Y. Leung. 2002. Smallpox vaccination: risk considerations for patients with atopic dermatitis. J. Allergy. Clin. Immunol. 110: 357-365.
5. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70: 8301-8309.
6. Harrington, L. E., R. Most Rv, J. L. Whitton, and R. Ahmed. 2002. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 76: 3329-3337.
7. + T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA 89: 6070-6074.
8. Xu, R., A. J. Johnson, D. Liggitt, and M. J. Bevan. 2004. Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 172: 6265-6271.
9. Edghill-Smith, Y., H. Golding, J. Manischewitz, L. R. King, D. Scott, M. Bray, A. Nalca, J. W. Hooper, C. A. Whitehouse, J. E. Schmitz, et al. 2005. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11: 740-747.
10. Hammarlund, E., M. W. Lewis, S. G. Hansen, L. I. Strelow, J. A. Nelson, G. J. Sexton, J. M. Hanifin, and M. K. Slifka. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9: 1131-1137.
11. + T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J. Exp. Med. 197: 927-932.
12. Drexler, I., C. Staib, W. Kastenmuller, S. Stevanovic, B. Schmidt, F.A. Lemonnier, H. G. Rammensee. D. H. Busch, H. Bernhard, V. Erfle, and G. Sutter. 2003. Identification of vaccinia virus epitope-specific HLA-A*0201- restricted T cells and comparative analysis of smallpox vaccines. Proc. Natl. Acad. Sci. USA 100: 217-222.
13. + T-cell peptide epitope of vaccinia and variola viruses. J. Virol. 78: 7052-7060.
14. Koelle, D. M. 2003. Expression cloning for the discovery of viral antigens and epitopes recognized by T-cells. Methods 29: 213-226.
15. + cytotoxic T lymphocytes in humans. J. Virol. 67: 1538-1544.
16. + herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J. Virol. 66: 1622-1634.
17. Koelle, D. M., H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey. 2001. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166: 4049-4058.
18. Posavad, C. M., A. Wald, N. Hosken, M. L. Huang, D. M. Koelle, R. L. Ashley, and L. Corey. 2003. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity? J. Immunol. 170: 4380-4388.
19. Koelle, D. M., Z. Liu, C. L. McClurkan, R. C. Cevallos, J. Vieira, N. A. Hosken, C. A. Meseda, D. C. Snow, A. Wald, and L. Corey. 2003. Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor. Proc. Natl. Acad. Sci. USA 100: 12899-12904.
20. Koelle, D. M., H. B. Chen, C. M. McClurkan, and E. W. Petersdorf. 2002. Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class 1 alleles. Blood 99: 3844-3847.
21. Upton, C., S. Slack, A. L. Hunter, A. Ehlers, and R. L. Roper. 2003. Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. J. Virol. 77: 7590-7600.
22. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
23. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152: 163-175.
24. Tartaglia, J., M. E. Perkus, J. Taylor, E. K. Norton. J. C. Audonnet, W. I. Cox, S. W. Davis, J. van der Hoeven, B. Meignier, M. Riviere, and et al. 1992. NYVAC: a highly attenuated strain of vaccinia virus. Virology 188: 217-232.
25. Goebel. S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179: 247-266, 517-563.
26. Brodie, S. J., D. A. Lewinsohn, B. K. Patterson, D. Jiyamapa, J. Krieger, L. Corey, P. D. Greenberg, and S. R. Riddell. 1999. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5: 34-41.
27. Moss, B. 2001. Poxviridae: the viruses and their replicatio. In Fields Virology. P.M. Howley, ed. Lippincott Williams & Wilkins, Philadelphia, pp. 2849-2883.
28. + T-cells specific for a skin-tropic virus. J. Clin. Invest. 110: 537-548.
29. Sette, A., and J. Sidney. 1998. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10: 478-482.
30. Marsh, S. G. E., P. Parham, and L. D. Barber. 2000. The HLA FactsBook. Academic Press, San Diego.
31. Antoine, G., F. Scheiflinger, F. Dorner, and F.G. Falkner. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244: 365-396.
32. + responses to viruses: cell biology, cellular immunology, and mathematical models. Immunity 21: 149-153.
33. Serna, A., M. C. Ramirez, A. Soukhanova, and L. J. Sigal. 2003. Cutting edge: efficient MHC class 1 cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol. 171: 5668-5672.
34. Fonteneau, J. F., D. G. Kavanagh, M. Lirvall, C. Sanders, T. L. Cover, N. Bhardwaj, and M. Larsson. 2003. Characterization of the MHC class 1 cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102: 4448-4455.
35. + T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201: 95-104.
36. Niedergang, F., A. Dautry-Varsat, and A. Alcover. 1997. Peptide antigen or superantigen-induced down-regulation of TCRs involves both stimulated and unstimulated receptors. J. Immunol. 159: 1703-1710.
37. + T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J. Gen. Virol. 86: 1997-2006.
38. Symons, J. A., E. Adams, D. C. Tscharke, P. C. Reading, H. Waldmann, and G.L. Smith. 2002. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J. Gen. Virol. 83: 2833-2844.
39. Rosel, J., and B. Moss. 1985. Transcriptional and translational mapping and nucleotide sequence analysis of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b. J. Virol. 56: 830-838.
40. Sanz, P., and B. Moss. 1999. Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression. Proc. Natl. Acad. Sci. USA 96: 2692-2697.
41. Patel, D. D., and D. J. Pickup. 1989. The second-largest subunit of the poxvirus RNA polymerase is similar to the corresponding subunits of procaryotic and eucaryotic RNA polymerases. J. Virol. 63: 1076-1086.
42. Hughes, S. J., L. H. Johnston, A. de Carlos, and G. L. Smith. 1991. Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevistae. J. Biol. Chem. 266: 20103-20109.
43. Colinas, R. J., S. J. Goebel, S. W. Davis, G. P. Johnson, E. K. Norton, and E. Paoletti. 1990. A DNA ligase gene in the Copenhagen strain of vaccinia virus is nonessential for viral replication and recombination. Virology 179: 267-275.
44. Senkevich, T. G., G. L. Muravnik, S. G. Pozdnyakov, V. E. Chizhikov, O. I. Ryazankina, S. N. Shehelkunov, E. V. Koonin, and V. I. Chernos. 1993. Nucleotide sequence of Xhol O fragment of ectromelia virus DNA reveals significant differences from vaccinia virus. Virus Res. 30: 73-88.
45. Myette, J. R., and E. G. Niles. 1996. Characterization of the vaccinia virus RNA 5'-triphosphatase and nucleotide triphosphate phosphohydrolase activities demonstrate that both activities are carried out at the same active site. J. Biol. Chem. 271: 11945-11952.
46. Morgan, J. R., L. K. Cohen, and B. E. Roberts. 1984. Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus. J. Virol. 52: 206-214.
47. Beaud, G. 1995. Vaccinia virus DNA replication: a short review. Biochimie 77: 774-779.
48. Langland, J. O., and B. L. Jacobs. 2004. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology 324: 419-429.
49. Yuwen, H., J. H. Cox, J. W. Yewdell, J. R. Bennink, and B. Moss. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195: 732-744.
50. van Eijl, H., M. Hollinshead, G. Rodger, W. H. Zhang, and G. L. Smith. 2002. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 83: 195-207.
51. Rochester, S. C., and P. Traktman. 1998. Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus 13 gene. J. Virol. 72: 2917-2926.
52. Welsch, S., L. Doglio, S. Schleich, and J. Krijnse Locker. 2003. The vaccinia virus I3L gene product is localized to a complex endoplasmic reticulum-associated structure that contains the viral parental DNA. J. Virol. 77: 6014-6028.
53. Reading, P. C., and G. L. Smith. 2003. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing γ interferon production and natural killer and T-cell activity. J. Virol. 77: 9960-9968.
54. Xiang, Y., D. A. Simpson, J. Spiegel, A. Zhou, R. H. Silverman, and R. C. Condit. 1998. The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor. J. Virol. 72: 7012-7023.